Developing a test to help treat leukaemia that has spread to the brain
Developing leukaemic biomarkers to enable personalised CNS-directed therapy
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Developing leukaemic biomarkers to enable personalised CNS-directed therapy
Defining the tumour microenvironment in extramedullary acute leukaemia
Testing the use of mebendazole and albendazole for children with acute myeloid leukaemia, and investigating how the drugs work.
Screening for novel drug combinations in childhood B-cell acute lymphoblastic leukaemia
Investigations into EVI1 mediated epigenetic modulation in childhood leukaemia